Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1 | 0 | 0 | 1 | 0 |
| Receivables | 1 | 0 | 0 | 1 | 0 |
| TOTAL | $2 | $0 | $0 | $2 | $0 |
| Non-Current Assets | |||||
| PPE Net | 37 | N/A | N/A | 37 | N/A |
| Intangibles | 193 | 0 | 0 | 193 | 0 |
| TOTAL | $230 | $N/A | $N/A | $230 | $N/A |
| Total Assets | $232 | $0 | $0 | $232 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $N/A | $0 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,112 | 0 | 0 | 2,112 | 0 |
| TOTAL | $2,112 | $N/A | $N/A | $2,112 | $N/A |
| Total Liabilities | $2,112 | $0 | $0 | $2,112 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,593 | 54,593 | 54,593 | N/A | N/A |
| Common Shares | 55 | 0 | 0 | 55 | 0 |
| Retained earnings | -30,550 | 0 | 0 | -30,550 | 0 |
| TOTAL | $-1,880 | $0 | $0 | $-1,880 | $0 |
| Total Liabilities And Equity | $232 | $0 | $0 | $232 | $0 |